Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26487 | 208 | 23.0 | 55% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1460 | 7267 | HOMEOPATHY//COMPLEMENTARY AND ALTERNATIVE MEDICINE//COMPLEMENTARY MEDICINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HS OS 1 | Author keyword | 6 | 100% | 2% | 4 |
| 2 | BRM BIOLOGICAL RESPONSE MODIFIER | Author keyword | 2 | 67% | 1% | 2 |
| 3 | DIAGNOST RADIOL RADIAT ONCOL | Address | 2 | 27% | 3% | 6 |
| 4 | DICHLORODIHYDROFLUORESCEIN DIACETATE H2DCFDA | Author keyword | 1 | 100% | 1% | 2 |
| 5 | HIGH LET LINEAR ENERGY TRANSFER RADIATION | Author keyword | 1 | 100% | 1% | 2 |
| 6 | SPG SCHIZOPHYLLAN | Author keyword | 1 | 100% | 1% | 2 |
| 7 | MANTLE FIELD | Author keyword | 1 | 40% | 1% | 2 |
| 8 | CYP17 ALPHA | Author keyword | 1 | 50% | 0% | 1 |
| 9 | DRUG INDUCED STEATOHEPATITIS | Author keyword | 1 | 50% | 0% | 1 |
| 10 | HOLLAND BIOMED | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CAF CHEMOTHERAPY | 30 | 79% | 9% | 19 |
| 2 | POSSIBLE REGULATORY SYSTEM | 26 | 87% | 6% | 13 |
| 3 | LINE HS OS 1 | 11 | 100% | 3% | 6 |
| 4 | OXYDOL RADIATION THERAPY | 4 | 75% | 1% | 3 |
| 5 | HS OS 1 | 3 | 100% | 1% | 3 |
| 6 | CONSERVATION TREATMENT | 3 | 24% | 6% | 12 |
| 7 | II KORTUC II | 2 | 67% | 1% | 2 |
| 8 | ADULT ARTICULAR CHONDROCYTES | 2 | 23% | 4% | 8 |
| 9 | LYSOSOMAL MEMBRANE DESTABILIZATION | 1 | 100% | 1% | 2 |
| 10 | UNRESECTABLE CARCINOMAS | 1 | 100% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Gene expression profiling of murine hepatic steatosis induced by tamoxifen | 2010 | 14 | 49 | 6% |
| Translational breast cancer research: Recent advances through the lens of experimental radiotherapy | 2010 | 0 | 7 | 14% |
| CLINICAL-SIGNIFICANCE OF CELLULAR-RESISTANCE IN TUMORS TO CYTOTOXIC CHEMOTHERAPY AND RADIOTHERAPY | 1993 | 3 | 27 | 4% |
| COMPUTERS IN RADIOTHERAPY | 1984 | 0 | 20 | 10% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DIAGNOST RADIOL RADIAT ONCOL | 2 | 27% | 2.9% | 6 |
| 2 | HOLLAND BIOMED | 1 | 50% | 0.5% | 1 |
| 3 | PEOPLES HOSP JIANGSU PROVINCE | 1 | 50% | 0.5% | 1 |
| 4 | TONGJI AFFILIATED HOSP | 1 | 50% | 0.5% | 1 |
| 5 | STATE INTERNAL MED | 0 | 17% | 0.5% | 1 |
| 6 | BIOMED INFORMAT MED | 0 | 11% | 0.5% | 1 |
| 7 | MED BIOPHYS UNIT | 0 | 11% | 0.5% | 1 |
| 8 | TUMOR RADIOL | 0 | 11% | 0.5% | 1 |
| 9 | CERRAHPASA MED ONCOL | 0 | 100% | 0.5% | 1 |
| 10 | DATA QUAL CONTROL UNIT | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000126076 | IRIDOLOGY//NATURAL HEALTH//UNPROVED METHODS |
| 2 | 0.0000092039 | MAIN MAGNET//NONLINEAR TRAJECTORY//LIE MAP |
| 3 | 0.0000084892 | RADIATION MYELOPATHY//LINEAR QUADRATIC MODEL//EXPT ZENTRUM |
| 4 | 0.0000072004 | ANTIPROTONIC HELIUM ATOM//ANTIPROTONIC HELIUM//ATOMCULE |
| 5 | 0.0000070095 | TAMOXIFEN//TOREMIFENE//DROLOXIFENE |
| 6 | 0.0000069748 | INDUCTION SYNCHROTRON//INDUCTION ACCELERATION//INDUCTION MODULE |
| 7 | 0.0000069500 | LIGHT ION PRODUCTION//NEUTRON THERAPY//KERMA COEFFICIENTS |
| 8 | 0.0000061844 | PROTON THERAPY//PENCIL BEAM SCANNING//PARTICLE THERAPY |
| 9 | 0.0000057104 | CALPAIN CATHEPSIN HYPOTHESIS//OSMOTIC SENSITIVITY//LYSOSOME STABILITY |
| 10 | 0.0000054626 | LOW DOSE HYPER RADIOSENSITIVITY//HYPER RADIOSENSITIVITY//ULTRAFRACTIONATION |